CLINICAL_TRIALS
trial_result
· 2019-12-04
Clinical Trial Update: Efficacy and Safety of Three Different Aflibercept Regimens in Subjects With Diabetic Macular Edema (DME) [Phase 3]
Summary
A Phase 3 clinical trial evaluating three aflibercept regimens for diabetic macular edema completed, with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Macular Edema | Phase 3 | Status: COMPLETED | Results posted: 2019-12-04